Patents on Rent: How India and ASEAN Are Turning Inventions into Licensing Gold
As of now, a patent is like a framed certificate rather than a business asset in many developing countries. You get it, store it. Maybe if someone copies it, you threaten to sue, but nobody really wants to go there. Something big has changed quietly over the last ten years in India and the ASEAN region. Patents are no longer for show. They are being licensed, traded, pooled and used to make money in ways that are starting to match what happens in countries. And in some cases, they are doing something entirely new. Here’s how two of the world’s exciting economic areas are learning to make the most of their inventions.
India: From Filing Cabinet to Revenue Stream
India has always had a complex relationship with intellectual property. A pre-1970 patent law that failed to acknowledge product patents in medicine, a deliberate policy that allowed generic manufacturers to thrive, helped the nation build its pharmaceutical industry. India did not just follow the American model when the WTO's TRIPS Agreement required a reconsideration. To adapt, it vigorously negotiated for flexibility. It insisted on standards such as Section 3(d) of the Patents Act, which raised the bar for patentability, a stance that continues to annoy international pharmaceutical corporations.
But the same suspicion of patents as monopoly tools is now giving way to a much more pragmatic interest in patents as income. Recorded over 30,000 patents granted by the Indian Patent Office in 2022-23. Indian companies - especially in IT, automobiles and pharma – are building portfolios with clear monetisation strategies in mind.
Think about how Indian IT companies are thinking about their inventions. The three companies have thousands of patents in areas such as cloud computing, AI-powered automation and cybersecurity. For years, they were filed mostly for prestige and client confidence, proof of innovation, not an asset class. That picture is changing. Licensing revenue, cross-licensing as a bargaining chip in enterprise deals and even patent assertion have all entered into conversations that would have seemed curiously American just ten years ago.
This has been the government’s involvement. The National IPR Policy of 2016 aimed specifically to change India from a consumer to a creator of intellectual property with commercialisation as an explicit objective. The movement for startup ecosystem support through DPIIT’s IP facilitation cells and, more recently, the discussion around technology transfer from government-funded research institutions is a recognition that India’s R&D spend needs a return, and licensing is one of the cleanest ways to generate that return.
The Compulsory Licensing Question
The compulsory licensing debate is a topic in Indian Patent Licensing that cannot be excluded from discussion. In 2012, India issued its first and only compulsory licence to date, forcing Bayer to license its kidney cancer drug Nexavar to a domestic generic producer for a fraction of the original price. The decision sent shock waves through pharmaceutical boardrooms in Europe and the US.
What is less discussed is how the mere existence of this mechanism affects licensing negotiations. Foreign patent holders have sometimes been more willing to negotiate voluntary licences on reasonable terms, to avoid the worst outcome, knowing that a compulsory licence is still a legal option. In this regard, compulsory licensing is not just an instrument of last resort; it is part of the bargaining framework that makes voluntary licensing work.
ASEAN: Ten Countries, One Aspiration, Many Realities
The picture in ASEAN countries is an interesting one, and a complicated one. Ten countries with very different standards for IP governance, ranging from Singapore with a world-class regime to Laos and Cambodia, still developing systems, are trying to put together something like an organised intellectual property framework.
Singapore is at the top of that ecosystem and has remained for several years. In Singapore, the combination of tax incentives for IP holding companies, a respected court system with specialist IP judges and keen positioning as a regional hub for licensing transactions has made the city-state the preferred location for multinationals to set up their Asia-Pacific IP holding vehicles. The Intellectual Property Office of Singapore (IPOS) has been actively promoting the adoption of IP valuation standards and a licensing-friendly environment. This is real substance, not marketing.
The more interesting story is the growth in Vietnam. A country that, until recently, was best known for the cost advantages it offered manufacturers is now actively developing an innovation sector. Vietnamese patent filings have increased dramatically in the last several years.
The administration implemented tax incentives relating to IP income. Foreign companies, especially in electronics and technology, are licensing technology to Vietnam more and more, rather than just setting up wholly owned subsidiaries – partly because the legal framework has become strong enough that licensing doesn’t feel like an act of faith.
Malaysia and Thailand are both in the centre. They have made large investments in pharmaceuticals and semiconductors, sectors in which patent licensing plays a structurally important role. Malaysia has attempted to create conditions conducive to technology licensing through its Multimedia Super Corridor and subsequent digital economy initiatives. Thailand’s ambitions in automotive technology and, more recently, medical devices mean that patent licensing is becoming increasingly central to how foreign technology enters the market.
The Cross-Border Challenge: Where Licensing Gets Messy
In the current scenario, cross-border intellectual property licensing in the India-ASEAN corridor remains extremely difficult, despite advancements. A portion of this is structural: patents are territorial rights, and a licence that applies in India may not apply in Malaysia or Indonesia. A licensing corporation has to meet different validity requirements, negotiate country by country, and contend with unpredictable courts.
But there is also a social dimension that is often neglected in policy debates. Patent licensing is a largely arms-length commercial transaction in the United States. Much of Asia still embeds it in longer-term relationships, where trust between licensor and licensee is as important as the contract terms and where disputes are more likely to be resolved through renegotiation rather than litigation. It outlines how the agreements are structured, how royalties are set, and how enforcement happens when things go wrong.
There’s still the issue of patent quality. Not everywhere in the world has rapid growth in filing been accompanied by improvements in examination quality. The Patent Office in India has a backlog, but it is getting better. Within ASEAN, the sophistication of the examination varies enormously. Weak patents – those that may not survive a challenge – create uncertainty that can chill as well as encourage licensing markets.
What Is Actually Different This Time
Predictions about Asia’s rise as an IP powerhouse have been around for at least two decades, and have largely failed to match reality. So, it’s worth asking, what is different now?
First, there is a real generational shift in the way engineers, entrepreneurs, and corporate legal teams in the region think about IP. The founders of the current wave of Indian deep-tech and Southeast Asian tech startups are not inclined to view patents as tools of colonialism or corporate monopoly - they see them as assets to be built, traded, and leveraged. That shift in mindset matters immensely.
Secondly, the infrastructure is improving. The idea of using property as collateral for loans or to attract investors is becoming more common in India and Singapore. People are creating rules to determine how much patents are worth, and courts are getting better at understanding them. These small but important changes are helping the market work better. IP finance is really important because it is changing how people think about patents, in these places. IP finance is making a difference, and it will keep changing how people view patents. The whole concept of IP finance is becoming a part of how business is done in India and Singapore.
Third, the technology stack is on its back. India and ASEAN are constructing real capabilities in areas such as AI, semiconductors, clean energy and biotech, where patent licensing is highly important. In these sectors, it is no longer just a user of foreign technology.
The Licensing Economy Is Still Being Written
The patent licensing market in India and ASEAN is still immature. The gaps- in enforcement, in quality, in cross-border harmonisation, in financial infrastructure - are real. But the direction of travel seems clear, and the rate of change has clearly picked up.
What emerges is not a simple imitation of the American patent-licensing model or a denial of it, but something more genuinely hybrid. A licensing culture conditioned by Asian relationship norms, post-colonial instincts about access and equity, rapidly growing innovation capacity, and a pragmatic interest in turning ideas into revenue.
Whether that hybrid model will be a genuine alternative to the Western template, or converge with it over time, will be one of the most interesting questions in global IP policy in the next decade. For the moment at least, the patent, long filed and forgotten across much of this region, is being called on to earn its keep at last.
Author :- Jatin Gupta, in case of any query, contact us at Global Patent Filing or write back us via email at support@globalpatentfiling.com.
References & Citations :
1- WIPO Global Innovation Index 2023
2- Indian Patent Office Annual Reports 2022-23
3- ASEAN IPR Action Plan 2016-2025
4- peer-reviewed articles in Journal of Intellectual Property Law & Practice
5- Asia Pacific Law Review and IDEA Law Review, policy documents of CII, DPIIT
6- MeitY (Government of India) and the Lee Kuan Yew School of Public Policy (NUS)